The cash-and-shares approach from Selkirk valued Myprotein at between £400 million and £600 million, THG said.
Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound
...
Read moreDetails
The cash-and-shares approach from Selkirk valued Myprotein at between £400 million and £600 million, THG said.
...
Read moreDetails...
Read moreDetails
...
Read moreDetails
...
Read moreDetails
...
Read moreDetails